[1]孙贺军.红元胶囊治疗老年患者髋部骨折疗效及对患者术后TPINP、FIB、N-MID水平的影响*[J].陕西中医,2019,(7):909-912.
　SUN Hejun..Effect of Hongyuan capsule on the level of TPINP,FIB and N-MID after hip fracture in elderly patients[J].,2019,(7):909-912.
点击复制

红元胶囊治疗老年患者髋部骨折疗效及对患者术后TPINP、FIB、N-MID水平的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年7期
页码:
909-912
栏目:
临床研究
出版日期:
2019-07-05

文章信息/Info

Title:
Effect of Hongyuan capsule on the level of TPINP,FIB and N-MID after hip fracture in elderly patients
文章编号:
DOI:10.3969/j.issn.1000-7369.2019.07.027
作者:
孙贺军
河南省驻马店市中心医院药学部（驻马店 463000）
Author(s):
SUN Hejun.
Department of Pharmacy,Zhumadian Central Hospital in Henan Province（Zhumadian 463000）
关键词:
红元胶囊; 老年髋部骨折; 总型前胶原氨基端延长肽; 纤维蛋白原; 端中段骨钙; 深静脉血栓
Keywords:
Key words Hongyuan capsule; Senile hip fracture; Total procollagen amino-terminal lengthening peptide; Fibrinogen; Mid-terminal osteocalcium; Deep venous thrombosis
分类号:
R683.3
文献标志码:
A
摘要:
摘 要 目的：探讨红元胶囊治疗老年患者髋部骨折的疗效及对术后总型前胶原氨基端延长肽（TPINP）、纤维蛋白原（FIB）、端中段骨钙（N-MID）的影响。方法：选取132例髋部骨折患者，采用随机数字法分为对照组和观察组，对照组患者给予低分子肝素钙治疗，观察组患者应用红元胶囊治疗，观察比较两组患者骨折愈合时间、深静脉血栓发生率及治疗前后TPINP、N-MID、FIB、凝血酶原时间（PT）、D-二聚体（D-D）水平变化情况和患肢肿胀程度差异。结果：治疗后观察组患者TPINP（42.08±1.03）mg/ml、N-MID（31.15±2.57）pg/ml明显优于对照组（P＜0.05）；治疗后观察组患者FIB（1.15±0.05）s、PT（12.99±0.65）s、D-D（7.05±2.63）mg/L与对照组比较无明显差异（P＞0.05）；治疗后观察组双大腿周径差值（1.39±0.21）cm、双小腿周径差值（0.80±0.16）cm同对照组比较明显提高（P＜0.05）。实验组患者骨折愈合时间（3.29±0.24）个月较对照组明显缩短（P＜0.05）。两组深静脉血栓发生率无差异（P＞0.05）。结论：针对老年髋部骨折患者术后应用红元胶囊可预防深静脉血栓，降低术后并发症，促进骨折愈合。
Abstract:
Abstract Objective:To investigate the effect of Hongyuan capsule on hip fracture in elderly patients and on the effect of total procollagen extension peptide(TPINP),fibrinogen(FIB),end bone calcium(N-MID) after operation.Methods:132 patients with hip fracture were randomly divided into control group and experimental group.The patients in control group were treated with low-molecular-weight heparin calcium,and those in experimental group were treated with Hongyuan capsule.The time of fracture healing,the incidence of deep venous thrombosis and the level of(PT),D-D before and after treatment were observed and compared between the two groups.Results:After treatment,the TPINP and N-MID in the trial group(42.08±1.03) mg/ml and the control group(31.15±2.57)pg/ml were significantly higher than those in the control group(P＜0.05),and the FIB(1.15±0.05) spT (12.99± 0.65) sTD-D(7.05±2.63) mg/L in the trial group was not significantly different from that in the control group(P＞0.05),and the thigh circumference difference was not significant in the test group after treatment(P＞0.05).The value of(1.39±0.21) cm,was significantly higher than that of the control group(0.80±0.16) cm(P＜0.05).The time of fracture healing in the experimental group(3.29±0.24) months was significantly shorter than that in the control group(P＜0.05).There was no difference in the incidence of deep venous thrombosis between the two groups(P＞0.05).Conclusion:The application of Hongyuan capsulefor the elderly hip fracture can prevent deep venous thrombosis,reduce postoperative complications and promote fracture healing.

参考文献/References:

[1] 梁玉柱,郭洪刚.老年骨质疏松性髋部骨折:昨天、今天及未来[J].中国组织工程研究,2017,21(15):2438-2443. [2] 王 欣.老年髋部骨折死亡危险因素的Meta分析[J].中国组织工程研究,2016,20(26):3929-3937. [3] 王 筠,顾晶亮,孙军平,等.血清BALp、TRAp-5b及Singh指数预测老年髋部骨折发生的临床应用价值[J].中国老年学杂志,2017,37(13):3280-3281. [4] 王晓伟,刘 智,张建政,等.老年髋部骨折术后发生谵妄危险因素分析[J].中华创伤杂志,2017,33(6):505-509. [5] 万永鲜,徐丽丽,卓乃强,等.老年髋部骨折患者围术期死亡风险评估[J].中华创伤杂志,2016,32(3):213-217. [6] 杨昌宇,胡芳铭,李汉军,等.超前镇痛联合多模式镇痛用于老年髋部骨折手术的效果及对患者炎性因子的影响[J].广东医学,2016,37(6):892-894. [7] Bliuc D,Alarkawi D,Nguyen TV,et al.Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density:the dubbo osteoporosis epidemiology study[J].Journal of Bone and Mineral Research:the Official Journal of the American Society for Bone and Mineral Research,2015,30(4):637-646. [8] 覃业语,王 敏,韦知樱,等.利伐沙班与低分子肝素预防老年髋部骨折患者深静脉血栓的疗效和安全性[J].中国老年学杂志,2016,36(17):4268-4269. [9] 陈俊南,PRANESH KY,唐 赢,等.利伐沙班和依诺肝素预防人工膝关节置换术后下肢深静脉血栓的临床研究[J].中国临床药理学杂志,2016,32(2):108-110. [10] 任军龙,杨雷刚,涂忠民,等.经股骨距防旋克氏针内固定治疗伴骨质疏松股骨转子间骨折22例[J].陕西医学杂志,2016,45(4):482-483. [11] 王海立,孙家元,张 弢,等.低分子肝素预防骨盆髋臼骨折后下肢深静脉血栓的临床研究[J].中华实验外科杂志,2016,33(8):2054-2056. [12] 许 昊,王培文,李毅中,等.骨密度检测对脆性髋部骨折患者骨质疏松诊疗率的影响[J].中华老年医学杂志,2017,36(7):784-787. [13] 陈 杰,陈 舰,邵印麟,等.中老年髋部骨折患者术后康复影响因素分析[J].山东医药,2016,56(4):42-43. [14] 程永远.益肾补骨汤联合椎体成形术治疗老年骨质疏松性胸腰椎压缩骨折临床观察[J].陕西中医,2017,38(1):76-78. [15] 沈 军,武理国,傅国海,等.活血治伤1号汤预防髋部骨折围手术期深静脉血栓形成的临床观察[J].浙江中医杂志,2016,51(7):507-508. [16] 张 莉,潘贤珍.益气补肾活血方联合穴位康复按摩对老年髋部骨折术后eNOS和NO的影响[J].现代中西医结合杂志,2016,25(31):3468-3470. [17] 刘路辉,刘 智.老年髋部骨折类型与股骨近端骨密度的关系[J].中国骨质疏松杂志,2017,23(4):477-482.

备注/Memo

备注/Memo:
*河南省科技攻关计划项目（1621023101823）
更新日期/Last Update: 2019-07-12